NASDAQ: AYTUAytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?
Insider buying vs selling
Have Aytu Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jarrett Disbrow | Chief Business Officer | 2025-06-09 | 16,666 | $1.50 | $25.00kBuy |
| Joshua R. Disbrow | Chief Executive Officer | 2025-06-09 | 66,666 | $1.50 | $100.00kBuy |
| Joshua R. Disbrow | Chief Executive Officer | 2025-02-28 | 15,000 | $1.30 | $19.50kBuy |
AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AYTU insiders and whales buy or sell their stock.
AYTU Shareholders
What type of owners hold Aytu Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 179.55% | 11,078,956 | $26.15M | Insider |
| Cerecor Inc | 157.42% | 9,713,068 | $22.92M | Insider |
| James B. Wiegand | 37.93% | 2,340,659 | $5.52M | Insider |
| Ampio Pharmaceuticals Inc | 19.88% | 1,226,407 | $2.89M | Insider |
| Christopher Brooke | 18.92% | 1,167,147 | $2.75M | Insider |
| Nantahala Capital Management LLC | 17.61% | 1,086,812 | $2.56M | Insider |
| Nantahala Capital Management LLC | 17.61% | 1,086,812 | $2.56M | Institution |
| Carl Dockery | 14.54% | 897,425 | $2.12M | Insider |
| Stonepine Capital Management LLC | 13.17% | 812,676 | $1.92M | Institution |
| Awm Investment Company Inc | 10.05% | 619,874 | $1.46M | Institution |
AYTU vs Pharmaceutical Stocks
Aytu Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.